Abstracts Archive - Page 2193 of 2425 - ACR Meeting Abstracts

Abstract Number: 859 • 2013 ACR/ARHP Annual Meeting
Knee Effusion: Sensitivity and Specificity Of Ultrasound For The Identification Of Calcium Pyrophosphate Crystals
Erika Catay¹, Santiago Ruta², Javier Rosa¹, David A. Navarta³, Marina Scolnik⁴, Ricardo Garcia-Monaco⁵ and Enrique R. Soriano⁶, ¹Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ²Rheumatology Unit, Internal Medical Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ³Internal Medicine, Rheumatology Unit, Internal Medical Services, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ⁴Rheumatology Section, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ⁵Radiology and Imagenology Department, Hospital italiano de Buenos Aires, Buenos Aires, Argentina, ⁶Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina
Background/Purpose: Calcium pyrophosphate deposition disease (CPPD) is an important cause of arthritis mainly in elderly people. The final diagnosis is based on the identification of…
Abstract Number: 861 • 2013 ACR/ARHP Annual Meeting
Many Gout Patients Treated By Rheumatologists Do Not Meet Established Treatment Goals Despite Long-Term Urate Lowering Therapy: Results Of a Gout Patient Encounter Survey
Max I. Hamburger¹, Michael H. Pillinger², Robert Sederman³ and Gary Fernandez⁴, ¹Rheumatology Associates, Melville, NY, ²NYU School of Medicine, Division of Rheumatology, New York, NY, ³C1 Consulting, LLC, Summit, NJ, ⁴Market Research, Savient Pharmaceuticals, Bridgewater, NJ
Background/Purpose: In Oct 2012, the ACR published guidelines for the management of gout. These guidelines recommend pharmacologic treatment that results in a sufficient lowering of…
Abstract Number: 862 • 2013 ACR/ARHP Annual Meeting
Ten-Year Incidence of Self-Reported Nonvertebral Fractures in 9,720 Japanese Patients With Rheumatoid Arthritis: A Prospective Observational Cohort Study
Kensuke Ochi¹, Takefumi Furuya¹, Eisuke Inoue², Katsunori Ikari¹, Atsuo Taniguchi², Hisashi Yamanaka¹ and Shigeki Momohara², ¹Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, ²Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan
Ten-Year Incidence of Self-reported Nonvertebral Fractures in 9,720 Japanese Patients with Rheumatoid Arthritis: A Prospective Observational Cohort Study Background/Purpose: Although rheumatoid arthritis (RA) is a…
Abstract Number: 863 • 2013 ACR/ARHP Annual Meeting
Romosozumab Administration Is Associated With Significant Improvements In Lumbar Spine and Hip Volumetric Bone Mineral Density and Content Compared With Teriparatide
H K Genant¹, S Boonen², M A Bolognese³, C Mautalen⁴, J P Brown⁵, C Recknor⁶, S Goemaere⁷, K Engelke⁸, Y-C Yang⁹, M Austin⁹, A Grauer⁹ and C Libanati⁹, ¹UCSF & Synarc Inc., San Francisco, CA, ²Leuven University Division of Geriatric Medicine, Leuven, Belgium, ³The Bethesda Health Research Center, Bethesda, MD, ⁴Centro de Osteopatias Medicas, Buenos Aires, Argentina, ⁵CHU de Québec Research Centre and Laval University, Québec, QC, Canada, ⁶United Osteoporosis Centers, Gainesville, GA, ⁷Ghent University Hospital, Ghent, Belgium, ⁸Synarc Germany, Hamburg, Germany, ⁹Amgen Inc., Thousand Oaks, CA
Background/Purpose: Sclerostin is an osteocyte-derived inhibitor of osteoblast activity. Romosozumab, a monoclonal antibody to sclerostin stimulates bone formation and decreases bone resorption. In a phase…
Abstract Number: 864 • 2013 ACR/ARHP Annual Meeting
Further Reduction In Nonvertebral Fracture Rate Is Observed Following 3 Years Of Denosumab Treatment: Results With Up To 7 Years In The Freedom Extension
Jonathan D. Adachi¹, Serge Ferrari², Carol Zapalowski³, Paul D. Miller⁴, Jean-Yves Reginster⁵, Ove Törring⁶, Nadia Daizadeh³, Andrea Wang³, Cynthia O'Malley⁷, Rachel B. Wagman³ and E. Michael Lewiecki⁸, ¹McMaster University, Hamilton, ON, Canada, ²Geneva University Hospital, Geneva, Switzerland, ³Amgen Inc., Thousand Oaks, CA, ⁴Colorado Center for Bone Research, Lakewood, CO, ⁵University of Liège, Liège, Belgium, ⁶Karolinska Institutet, Södersjukhuset, Stockholm, Sweden, ⁷Center for Observational Research, Amgen, Inc., Thousand Oaks, CA, ⁸New Mexico Clinical Research & Osteoporosis Center, Albuquerque, NM
Further Reduction in Nonvertebral Fracture Rate Is Observed Following 3 Years of Denosumab Treatment: Results With up to 7 Years in the FREEDOM ExtensionBackground/Purpose: Some…
Abstract Number: 865 • 2013 ACR/ARHP Annual Meeting
Vertebral Fractures In The 3 Year Period Following Steroid Initiation Among Children With Chronic Illnesses
Johannes Roth¹, Jinhui Ma¹, David A. Cabral², Peter B. Dent³, Janet E. Ellsworth⁴, Adam M. Huber⁵, Kristin M. Houghton², Roman Jurencak¹, Bianca A. Lang⁵, Maggie Larche³, Claire MA Leblanc⁶, Brian Lentle², MaryAnn Matzinger¹, Paivi M. Miettunen⁷, Kiem Oen⁸, Claire Saint-cyr⁹, Rosie Scuccimarri¹⁰, Nazih Shenouda¹, Leanne M. Ward¹ and The Canadian STOPP Consortium¹¹, ¹University of Ottawa, Ottawa, ON, Canada, ²University of British Columbia, Vancouver, BC, Canada, ³McMaster University, Hamilton, ON, Canada, ⁴University of Alberta, Edmonton, AB, Canada, ⁵Dalhousie University, Halifax, NS, Canada, ⁶McGill University, Montréal, QC, Canada, ⁷University of Calgary, Calgary, AB, Canada, ⁸University of Manitoba, Winnipeg, MB, Canada, ⁹Université de Montréal, Montreal, QC, Canada, ¹⁰McGill University, Montreal, QC, Canada, ¹¹National Pediatric Bone Health Working Group, Ottawa, ON, Canada
Background/Purpose: : To describe the pattern and frequency of incident vertebral fractures (VF) in glucocorticoid (GC)-treated children and to determine the clinical factors at baseline…
Abstract Number: 866 • 2013 ACR/ARHP Annual Meeting
Use Of Non Steroidal Anti-Inflammatory Drugs Prevent Bone Loss In Patients With Early Inflammatory Back Pain: Results From The DESIR Cohort
Karine Briot¹, Simon Paternotte², Corinne Miceli-Richard³, Maxime Dougados^2,4 and Christian Roux¹, ¹Cochin hospital, Paris Descartes University, Paris, France, ²Cochin Hospital, Paris Descartes University, Paris, France, ³Rheumatology, Université Paris Sud, Le Kremlin Bicêtre, France, ⁴Université Paris René Descartes and Hôpital Cochin, Paris, France
Background/Purpose: To assess the 2-year bone mineral density (BMD) changes at lumbar spine and hip in a large cohort of patients with early inflammatory back…
Abstract Number: 867 • 2013 ACR/ARHP Annual Meeting
Reduced Hip Cortical Porosity Upon Denosumab Treatment: A Likely Mechanism Contributing To The Reduction Of Hip Fracture Risk In Women With Osteoporosis
R. M. Zebaze¹, C. Libanati², M. R. McClung³, J. R. Zanchetta⁴, D. L. Kendler⁵, A. Høiseth⁶, A. Wang², A. Ghasem-Zadeh¹ and E. Seeman¹, ¹Austin Health, University of Melbourne, Melbourne, Australia, ²Amgen Inc., Thousand Oaks, CA, ³Oregon Osteoporosis Center, Portland, OR, ⁴Instituto de Investigaciones Metabólicas, Buenos Aires, Argentina, ⁵University of British Columbia, Vancouver, BC, Canada, ⁶Curato Røntgen, Oslo, Norway
Background/Purpose: Nonvertebral fracture risk is significantly influenced by cortical thickness, area, mass, and porosity because all of these contribute to bone strength. In particular, increased…
Abstract Number: 834 • 2013 ACR/ARHP Annual Meeting
Physical Activity Behavior In Patients With Arthritis
Gustavo J. Almeida¹ and Sara R. Piva², ¹Department of Physical Therapy, University of Pittsburgh, Pittsburgh, PA, ²Physical Therapy, University of Pittsburgh, Pittsburgh, PA
Background/Purpose: : The physical activity (PA) guidelines issued by the US Health and Human Services (HHS) recommend that adults with arthritis should perform at least…
Abstract Number: 843 • 2013 ACR/ARHP Annual Meeting
Endogenous Pain Modulation In The Ehlers-Danlos Syndrome, Hypermobility Type
Inge De Wandele, Department of Rehabilitation Sciences and Physiotherapy, Ghent University, Ghent, Belgium
Background/Purpose: The Ehlers-Danlos Syndrome (EDS) is the most prevalent heritable connective tissue disorder. More than 90% of individuals are classified as having the hypermobility type…
Abstract Number: 828 • 2013 ACR/ARHP Annual Meeting
Psychosocial Determinants Of Total Knee Arthroplasty Outcomes 2 Years After Surgery
Aparna Ingleshwar¹, Maria A. Lopez-Olivo², Glenn C. Landon³, Sherwin J. Siff³, Andrea Barbo⁴ and Maria E. Suarez-Almazor⁵, ¹General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, ²General Internal Medicine, University of Texas. M.D Anderson Cancer Center, Houston, TX, ³St. Luke's Episcopal Health System, Houston, TX, ⁴Department of Biostatistics, The University of Texas, MD Anderson Cancer Center, Houston, TX, ⁵The Department of General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX
Background/Purpose: To explore potential psychosocial and demographic factors that influence Total Knee Arthroplasty (TKA) outcomes and satisfaction at 24 months. Methods: A prospective cohort study…
Abstract Number: 829 • 2013 ACR/ARHP Annual Meeting
Is The Severity Of Knee Osteoarthritis On MRI Associated With Outcome Of Exercise Therapy?
Jesper Knoop¹, Joost Dekker², Marike van der Leeden^3,4, Martin van der Esch⁴, J.P. Klein⁵, David J. Hunter⁶, Leo D. Roorda⁴, Martijn P.M. Steultjens⁷ and Willem F. Lems⁸, ¹Amsterdam Rehabilitation Research Center, Reade, centre for rehabilitation and rheumatology, Amsterdam, Netherlands, ²Rehabilitation Medicine, Psychiatry and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, Netherlands, ³Rehabilitation Medicine/EMGO, VU University Medical Center, Amsterdam, Netherlands, ⁴Amsterdam Rehabilitation Research Center | Reade, Amsterdam, the Netherlands, Amsterdam, Netherlands, ⁵Radiology, VU University Medical Center, Amsterdam, Netherlands, ⁶Rheumatology, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia, ⁷Institute for Applied Health Research and School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, Scotland, ⁸Rheumatology, VU University Medical Center, Amsterdam, Netherlands
Background/Purpose: To evaluate associations between severity of knee osteoarthritis (OA) on MRI and treatment outcome in knee OA patients treated with exercise therapy. Methods: Ninety-five…
Abstract Number: 830 • 2013 ACR/ARHP Annual Meeting
Ethnic Variations At Time Of Surgery and During Follow-Up In Patients Undergoing Total Knee Arthroplasty
Aparna Ingleshwar¹, Andrea Barbo², Glenn C. Landon³, Sherwin J. Siff³, Sofia De Achaval⁴ and Maria E. Suarez-Almazor⁵, ¹General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX, ²Department of Biostatistics, The University of Texas, MD Anderson Cancer Center, Houston, TX, ³St. Luke's Episcopal Health System, Houston, TX, ⁴General Internal Medicine, U.T. MD Anderson Cancer Center, Houston, TX, ⁵The Department of General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX
Background/Purpose: Literature reports sizable improvements in pain and function in patients having undergone Total Knee Arthroplasty (TKA) procedure. However, significant disparities exist in the utilization…
Abstract Number: 831 • 2013 ACR/ARHP Annual Meeting
Relationships Between Clinical Outcome Measures and Gait Variables Before and After Total Hip Arthroplasty
Kharma C. Foucher^1,2 and Omar Behery³, ¹Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, IL, ²Orthopedic Surgery, Rush University Medical Center, Chicago, IL, ³Rush University Medical Center, Chicago, IL
Background/Purpose: Inadequate clinical response in a substantial portion of total hip arthroplasty (THA) patients, 1 as well as gait deficits after THA 2 have been…
Abstract Number: 832 • 2013 ACR/ARHP Annual Meeting
Factors That Affect Tender and Swollen Joint Counts In Rheumatoid Arthritis
Christine L. Amity¹, Marisa Eckels², Kenneth N. Gold³, Kelly A. Reckley⁴, Niveditha Mohan⁵, Stephen R. Wisniewski⁶, Elizabeth A. Schlenk⁷, Marc C. Levesque^8,9 and Terence W. Starz¹⁰, ¹Rheumatology & Clinical Immun, Univ of Pittsburgh, Pittsburgh, PA, ²Arthritis and Internal Medicine Associates, University of Pittsburgh Medical Center, Pittsburgh, PA, ³Arthritis & Internal Medicine, Pittsburgh, PA, ⁴Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, ⁵Div of Rheum & Clin Immunol, Univ of Pittsburgh Arth Inst, Pittsburgh, PA, ⁶Epidemiology Data Center, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, ⁷School of Nursing, University of Pittsburgh, Pittsburgh, PA, ⁸Division of Rheumatology and Clinical Immunology, University of Pittsburgh Department of Medicine, Pittsburgh, PA, ⁹Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, ¹⁰Arth & Internal Med Associates, Pittsburgh, PA
Background/Purpose: Quantitative joint counts are used to determine rheumatoid arthritis (RA) disease activity and are increasingly important for routine clinical practice to optimize patient care.…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].